Executive hire brings deep industry insight and
expertise
VANCOUVER, March 21, 2019 /CNW/ - BLOCKStrain Technology
Corp. (TSX:V: DNAX.V) (OTC: BKKSF) ("BLOCKStrain"), creator of the
first Blockchain-secured, fully-integrated IP tracking platform for
the cannabis industry, today announced it has appointed Dr.
James LaValle as it Chief Medical
Manager. In this new role, Dr. LaValle will provide leadership and
direction with respect to scientific and medical aspects of the
core software of the company, as well as areas of additional
product and business development.
Dr. James LaValle has more than
40 years of experience in the natural products industry as a
clinician, industry consultant and educator. He has dedicated
his professional career to becoming a voice for the emerging value
of the natural product industry, with particular emphasis on the
need for quality standards and transparency of ingredients in order
to ensure consumer safety and efficacy.
"While Cannabidiol from hemp and cannabis products are taking
the consumer and medical markets by storm, to date, this market
segment has been fraught with quality and contamination issues that
have tarnished the enormous value that these compounds can provide
consumers. The BLOCKStrain technology represents a necessary
evolution in ensuring product quality by tracking and reporting CBD
and Cannabis ingredients starting from the soil all the way to the
products on the store shelf", stated Dr. LaValle. "The CBD/Cannabis
industry must deliver quality finished goods to a level that
inspires consumer confidence and provides them with safe
products. Verification of the level and type of active
ingredients as well as absence of impurities should be simple, but
the industry is riddled with inconsistent and in some cases
dangerous final products. I firmly believe BLOCKStrain has
the potential to become a new standard for testing and reporting
purity and content safety of not just cannabis, but other natural
products as well."
"Dr. LaValle's immense expertise in the nutraceutical industry,
and his dedication to ensuring high quality product standards is
directly in line with BLOCKStrain's mission of bringing
transparency and integrity to the cannabis industry. With our
technology, licensed producers, craft growers, other industry
participants and most importantly patients and customers, can take
affirmative action to ensure their products are as advertised."
said Robert Galarza, CEO of
BLOCKStrain. "Dr. LaValle's valued insight and well-established
brand presence in the nutraceutical industry is unquestioned, and
we are excited to have him as a key part of our growth strategy in
cannabis and beyond."
Dr. LaValle is the recipient of many prestigious awards. He was
one of nine Americans chosen for the Inaugural Dietary Supplement
Information Bureau Board, and was also awarded the Clinician of the
Year Award from the Natural Products Association. He has authored 4
databases on natural products and teaches application of natural
compounds in clinical practice to health care professionals around
the world. In addition, he has 35 years of clinical practice
in integrative medicine.
In connection with this appointment BLOCKStrain has agreed to
grant Dr. LaValle stock options to acquire up to 250,000 common
shares in the capital of BLOCKStrain, subject to the terms of a
stock option agreement to be entered into by the parties.
About BLOCKStrain:
BLOCKStrain has developed the first integrated blockchain
platform to register and track intellectual property in the
cannabis industry. BLOCKStrain's technology allows cannabis growers
and breeders to identify and secure rights to their intellectual
property. It also streamlines the administrative process and
reduces the costs of genetic and mandatory quality-control testing
for legal cannabis. BLOCKStrain's technology is proprietary,
immutable and cryptographically secure, thereby establishing a
single-source, accurate, validated, and permanent account for
cannabis strains from ownership to market.
Forward-Looking Information:
The forward-looking information in this news release is based
upon the expectations, estimates, projections, assumptions and
views of future events which management believes to be reasonable
in the circumstances. Forward-looking information includes
estimates, plans, expectations, opinions, forecasts, projections,
targets, guidance or other statements that are not statements of
fact. Forward-looking statements in this news release include
statements regarding: the Chief Medical Manager's anticipated role
with BLOCKStrain and that his expertise will benefit BLOCKStrain;
the statement with respect to the emerging value of the natural
products industry, including compounds containing cannabidiol from
hemp and cannabis; that BLOCKStrain technology has the potential to
become a new standard for testing and reporting purity and content
safety for cannabis and other natural products; and statements
regarding the business of the Company. Forward-looking information
necessarily involves known and unknown risks, including,
without limitation, risks associated with general economic
conditions; adverse industry events; loss of markets; changes to
the growth and size of the natural product industry; consumer
acceptance and adoption of natural products, including compounds
containing cannabidiol from hemp and cannabis as compared to other
products; future legislative and regulatory developments; inability
to access sufficient capital from internal and external sources,
and/or inability to access sufficient capital on favourable terms;
the cannabis industry in Canada
generally; the ability of BLOCKStrain to implement its business
strategies; competition; and other risks. These forward-looking
statements are made as of the date hereof and BLOCKStrain disclaims
any intent or obligation to update publicly any forward-looking
statements, whether as a result of new information, future events
or results or otherwise, except as required by applicable
securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE .
SOURCE BLOCKStrain Technology Corp.